Boundless Bio, Inc. - BOLD

SEC FilingsOur BOLD Tweets

About Gravity Analytica

Recent News

  • 06.05.2025 - Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
  • 06.05.2025 - Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
  • 05.27.2025 - Boundless Bio Conference Call
  • 05.27.2025 - Boundless Bio Conference Call
  • 05.23.2025 - Boundless Bio Announces Portfolio Prioritization and Runway Extension
  • 05.23.2025 - Boundless Bio Announces Portfolio Prioritization and Runway Extension
  • 05.09.2025 - Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
  • 05.09.2025 - Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
  • 04.10.2025 - Needham Virtual Healthcare Conference
  • 04.10.2025 - Needham Virtual Healthcare Conference

Recent Filings

  • 05.23.2025 - 8-K Current report
  • 05.09.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.09.2025 - EX-99.1 EX-99.1
  • 05.09.2025 - 8-K Current report
  • 04.29.2025 - ARS Annual Report to Security Holders
  • 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 04.29.2025 - DEF 14A Other definitive proxy statements
  • 04.10.2025 - EFFECT Notice of Effectiveness
  • 04.08.2025 - UPLOAD SEC-generated letter
  • 04.08.2025 - CORRESP Correspondence